ADIAL PHARMACEUTICALS, INC. - 8-K Filing
Adial Pharmaceuticals stockholders approved equity plan amendments and new incentive plans at the annual meeting on September 17, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $ADIL